Search results
Regeneron touts success with bispecific antibody in multiple myeloma trial
Clinical Trials Arena via Yahoo Finance· 18 hours agoRegeneron has released encouraging trial results for its multiple myeloma antibody, linvoseltamab....
Gateway - Quartz
Quartz· 1 hour agoHumira, a monoclonal antibody used to treat arthritis among other conditions, is the most lucrative drug in history. Since entering the market in 2003, it has made its manufacturer ...
Anti-Ro/SSA Antibodies Have Potential to Predict ILD in SSc
Medscape· 4 days agoAnti-Ro/SSA antibodies may help predict which patients with systemic sclerosis (SSc) are at a...
Principal Investigator Positions at the Institute for Regenerative Biology and Medicine, CIMR -...
Nature· 24 minutes agoRegenerative Biology and Medicine encompasses interdisciplinary biological and translational fields that aims to subvert human disease, trauma and aging. Within the frame of the Chinese Institutes ...
What are the symptoms of Lyme disease? It's a broad range.
USA TODAY via Yahoo News· 50 minutes agoWhy did it take a pandemic for attention to be drawn to this debilitating condition? It’s complicated. One of the major reasons for this is that the testing for Lyme disease is imperfect. The ...
Scientists engineer human antibodies that could neutralize black widow toxin
Medical Xpress· 6 days agoThere are various types of widow spiders, including black, red, and brown varieties in North and...
Invivyd reports antibody neutralization of new COVID variants By Investing.com
Investing.com· 4 days agoInvivyd, Inc. (NASDAQ:IVVD), a biopharmaceutical company, announced today that its investigational...
SEHK Growth Companies With High Insider Ownership Showcasing Promising Futures
Simply Wall St. via Yahoo Finance· 2 hours agoAmidst a landscape of fluctuating global markets, the Hong Kong stock market continues to present...
What causes long COVID? Case builds for rogue antibodies
Nature· 5 days agoStudy finds that antibodies from people with the debilitating condition trigger similar symptoms in...
Mozart Therapeutics doses first patients in trial of MTX-101 for autoimmune diseases
Clinical Trials Arena via Yahoo Finance· 59 minutes ago“The aim of MTX-101 is to selectively target a fundamental cause of immune dysregulation and restore...
